Information Provided By: 
Fly News Breaks for April 28, 2017
EXAS
Apr 28, 2017 | 07:46 EDT
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $38 from $27 following Q1 results. The analyst said the company's growth is faster than expected, which demonstrates its leverage in its business. The company beat Q1 estimates across the board, said Massaro, who added that Exact Sciences remains a top pick for 2017 and reiterated his Buy rating on the shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
